Cubist Systematic Strategies, LLC Illumina, Inc. Call Options Transaction History

Cubist Systematic Strategies, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$105.28 - $135.9 $63,168 - $81,540	600 Added 2.53%	24,300 $3.17 Million
Q2 2024 Aug 14, 2024	SELL	$101.05 - $133.57 $2.6 Million - $3.43 Million	-25,700 Reduced 52.02%	23,700 $2.47 Million
Q1 2024 May 15, 2024	SELL	$127.73 - $147.2 $651,423 - $750,720	-5,100 Reduced 9.36%	49,400 $6.78 Million
Q4 2023 Feb 14, 2024	BUY	$92.79 - $142.53 $2.59 Million - $3.98 Million	27,900 Added 104.89%	54,500 $7.59 Million
Q3 2023 Nov 14, 2023	BUY	$128.91 - $192.44 $1.31 Million - $1.96 Million	10,200 Added 62.2%	26,600 $3.65 Million
Q2 2023 Aug 14, 2023	BUY	$183.43 - $232.67 $3.01 Million - $3.82 Million	16,400 New	16,400 $3.07 Million
Q4 2022 Feb 14, 2023	BUY	$187.24 - $242.74 $730,236 - $946,686	3,900 Added 86.67%	8,400 $1.7 Million
Q3 2022 Nov 14, 2022	BUY	$177.23 - $227.44 $797,535 - $1.02 Million	4,500 New	4,500 $859,000

900

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $21.9B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.